Swollen to tender joint count ratio: a novel combination of routine measures to assess pain and treatment response in rheumatoid arthritis.
作者信息
Lee Yvonne C
机构信息
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
出版信息
Arthritis Care Res (Hoboken). 2014 Feb;66(2):171-2. doi: 10.1002/acr.22106.
Abstract
摘要
相似文献
1
Swollen to tender joint count ratio: a novel combination of routine measures to assess pain and treatment response in rheumatoid arthritis.
Arthritis Care Res (Hoboken). 2014 Feb;66(2):171-2. doi: 10.1002/acr.22106.
2
Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.
Arthritis Care Res (Hoboken). 2014 Feb;66(2):173-9. doi: 10.1002/acr.22107.
3
Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: comment on the article by Sokka and Pincus.
Arthritis Rheum. 2003 Dec;48(12):3611-3; author reply 3613-5. doi: 10.1002/art.11335.
4
[TNF-inhibitors slow down joint destruction in rheumatoid arthritis. No cure, but dramatic relief of symptoms].
Lakartidningen. 2001 May 23;98(21):2560-2.
5
Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.
Ann Rheum Dis. 2006 Jul;65(7):878-83. doi: 10.1136/ard.2005.044131. Epub 2005 Dec 8.
6
Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis.
Clin Exp Rheumatol. 2013 Jan-Feb;31(1):154. Epub 2012 Nov 22.
7
Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
J Rheumatol. 2006 Mar;33(3):490-7.
8
Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
J Rheumatol. 2008 Mar;35(3):372-4.
9
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study.
Ann Rheum Dis. 2012 Nov;71(11):1861-4. doi: 10.1136/annrheumdis-2012-201324. Epub 2012 Jun 26.
10
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Arthritis Rheum. 2005 Apr;52(4):1020-30. doi: 10.1002/art.20982.
引用本文的文献
1
Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RA.
J Clin Rheumatol. 2024 Aug 1;30(5):193-199. doi: 10.1097/RHU.0000000000002091. Epub 2024 May 1.
2
Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients.
Rheumatology (Oxford). 2024 Mar 1;63(3):734-741. doi: 10.1093/rheumatology/kead278.
3
A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA.
Rheumatol Ther. 2023 Feb;10(1):261-274. doi: 10.1007/s40744-022-00509-x. Epub 2022 Dec 5.
4
Latin American Genes: The Great Forgotten in Rheumatoid Arthritis.
J Pers Med. 2020 Oct 26;10(4):196. doi: 10.3390/jpm10040196.
5
Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study.
BMJ Open. 2014 Jan 3;4(1):e004313. doi: 10.1136/bmjopen-2013-004313.
本文引用的文献
1
Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.
Arthritis Care Res (Hoboken). 2014 Feb;66(2):173-9. doi: 10.1002/acr.22107.
2
The role of sleep problems in central pain processing in rheumatoid arthritis.
Arthritis Rheum. 2013 Jan;65(1):59-68. doi: 10.1002/art.37733.
3
Fibromyalgia in patients with rheumatoid arthritis: driven by depression or joint damage?
Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69):S88-91. Epub 2012 Jan 3.
4
The prevalence of fibromyalgia in other chronic pain conditions.
Pain Res Treat. 2012;2012:584573. doi: 10.1155/2012/584573. Epub 2011 Nov 17.
5
The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia.
Arthritis Res Ther. 2011 Apr 28;13(2):211. doi: 10.1186/ar3306.
6
The development of fibromyalgia--I: examination of rates and predictors in patients with rheumatoid arthritis (RA).
Pain. 2011 Feb;152(2):291-299. doi: 10.1016/j.pain.2010.09.027. Epub 2010 Oct 18.
7
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.
Rheumatology (Oxford). 2011 Jan;50(1):117-23. doi: 10.1093/rheumatology/keq209. Epub 2010 Jul 29.
8
Fibromyalgic rheumatoid arthritis and disease assessment.
Rheumatology (Oxford). 2010 May;49(5):924-8. doi: 10.1093/rheumatology/kep458. Epub 2010 Jan 25.
9
Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.
Ann Rheum Dis. 2007 Nov;66(11):1485-90. doi: 10.1136/ard.2007.069765. Epub 2007 May 1.
Zotero 插件